FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3091892384> ?p ?o ?g. }

• W3091892384 endingPage "241" @default.
• W3091892384 startingPage "230" @default.
• W3091892384 abstract "To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19. Generar las recomendaciones para la atención de pacientes con enfermedades reumáticas que reciben terapias inmunomoduladoras e inmunosupresoras (fármacos convencionales, biológicos y moléculas pequeñas) durante la pandemia por COVID-19. Las recomendaciones se realizaron utilizando el método Delphi como herramienta de acuerdo. Se conformó un panel de expertos con trayectoria académica y experiencia en investigación en reumatología. Se realizó la búsqueda de la literatura y se generó el cuestionario del ejercicio Delphi conformado por 42 preguntas. El grado de acuerdo se logró con el 80% de aprobación de los participantes. Se conformó un grupo de 11 reumatólogos de 7 ciudades del país. La tasa de respuesta fue del 100% para las 3 rondas de consulta. En la primera ronda se logró acuerdo en 35 preguntas, en la segunda ronda 37 y en la tercera ronda se logró el acuerdo de las 42 preguntas. La recomendación para la mayoría de los tratamientos inmunomoduladores utilizados en reumatología es continuar con las terapias en pacientes que no tengan la infección y suspenderlas en aquellos con diagnóstico de SARS-CoV-2/COVID-19." @default.
• W3091892384 created "2020-10-15" @default.
• W3091892384 creator A5002508340 @default.
• W3091892384 creator A5006996011 @default.
• W3091892384 creator A5010081250 @default.
• W3091892384 creator A5011301317 @default.
• W3091892384 creator A5025593351 @default.
• W3091892384 creator A5032262781 @default.
• W3091892384 creator A5040742321 @default.
• W3091892384 creator A5059519400 @default.
• W3091892384 creator A5064940057 @default.
• W3091892384 creator A5071221560 @default.
• W3091892384 creator A5081569645 @default.
• W3091892384 date "2020-07-01" @default.
• W3091892384 modified "2023-10-10" @default.
• W3091892384 title "Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology" @default.
• W3091892384 cites W113690342 @default.
• W3091892384 cites W1497514376 @default.
• W3091892384 cites W1521666696 @default.
• W3091892384 cites W1981610922 @default.
• W3091892384 cites W1986456458 @default.
• W3091892384 cites W2003168056 @default.
• W3091892384 cites W2003916139 @default.
• W3091892384 cites W2046902509 @default.
• W3091892384 cites W2053380345 @default.
• W3091892384 cites W2055923601 @default.
• W3091892384 cites W2057605053 @default.
• W3091892384 cites W2072829987 @default.
• W3091892384 cites W2077933909 @default.
• W3091892384 cites W2083521902 @default.
• W3091892384 cites W2088550293 @default.
• W3091892384 cites W2099074608 @default.
• W3091892384 cites W2101884425 @default.
• W3091892384 cites W2136525664 @default.
• W3091892384 cites W2136905810 @default.
• W3091892384 cites W2140073887 @default.
• W3091892384 cites W2143177540 @default.
• W3091892384 cites W2157749015 @default.
• W3091892384 cites W2158238638 @default.
• W3091892384 cites W2159882189 @default.
• W3091892384 cites W2162448828 @default.
• W3091892384 cites W2170984368 @default.
• W3091892384 cites W2206693472 @default.
• W3091892384 cites W2218477436 @default.
• W3091892384 cites W2292646251 @default.
• W3091892384 cites W2624322160 @default.
• W3091892384 cites W2773804840 @default.
• W3091892384 cites W2796022095 @default.
• W3091892384 cites W2890221919 @default.
• W3091892384 cites W2925144002 @default.
• W3091892384 cites W2943278075 @default.
• W3091892384 cites W2947452967 @default.
• W3091892384 cites W2992089985 @default.
• W3091892384 cites W3004919484 @default.
• W3091892384 cites W3005212621 @default.
• W3091892384 cites W3005403371 @default.
• W3091892384 cites W3007546470 @default.
• W3091892384 cites W3008763357 @default.
• W3091892384 cites W3009389929 @default.
• W3091892384 cites W3009799538 @default.
• W3091892384 cites W3010930696 @default.
• W3091892384 cites W3011047976 @default.
• W3091892384 cites W3011183720 @default.
• W3091892384 cites W3011558436 @default.
• W3091892384 cites W3011802905 @default.
• W3091892384 cites W3011957742 @default.
• W3091892384 cites W3012421327 @default.
• W3091892384 cites W3012615836 @default.
• W3091892384 cites W3014050022 @default.
• W3091892384 cites W3014333693 @default.
• W3091892384 cites W3014569663 @default.
• W3091892384 cites W3015018920 @default.
• W3091892384 cites W3015861468 @default.
• W3091892384 cites W3022970339 @default.
• W3091892384 cites W4205363739 @default.
• W3091892384 doi "https://doi.org/10.1016/j.rcreue.2020.10.001" @default.
• W3091892384 hasPublicationYear "2020" @default.
• W3091892384 type Work @default.
• W3091892384 sameAs 3091892384 @default.
• W3091892384 citedByCount "2" @default.
• W3091892384 countsByYear W30918923842021 @default.
• W3091892384 countsByYear W30918923842023 @default.
• W3091892384 crossrefType "journal-article" @default.
• W3091892384 hasAuthorship W3091892384A5002508340 @default.
• W3091892384 hasAuthorship W3091892384A5006996011 @default.
• W3091892384 hasAuthorship W3091892384A5010081250 @default.
• W3091892384 hasAuthorship W3091892384A5011301317 @default.
• W3091892384 hasAuthorship W3091892384A5025593351 @default.
• W3091892384 hasAuthorship W3091892384A5032262781 @default.
• W3091892384 hasAuthorship W3091892384A5040742321 @default.
• W3091892384 hasAuthorship W3091892384A5059519400 @default.
• W3091892384 hasAuthorship W3091892384A5064940057 @default.
• W3091892384 hasAuthorship W3091892384A5071221560 @default.
• W3091892384 hasAuthorship W3091892384A5081569645 @default.
• W3091892384 hasBestOaLocation W30918923841 @default.
• W3091892384 hasConcept C105795698 @default.
• W3091892384 hasConcept C116675565 @default.
• W3091892384 hasConcept C126322002 @default.

• next